ACE I/D polymorphism predicts end stage renal disease and or mortality in type I diabetic patients except for those with already advanced nephropathy: the follow up of the Genesis/Genediab Studies; ; et al in Diabetologia (2007, September), 50(Suppl. 1), 157-158 Detailed reference viewed: 12 (0 ULg) |
||